COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.6 | 4 | 0065-0405 | 765.45 | 405.15 | 309 | 65.60 | 0.902 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 233.2 | 4 | 0066-0407 | 710.17 | 407.47 | 313 | 64.43 | 0.948 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 279.1 | 4 | 0067-0411 | 327.72 | 411.45 | 279 | 64.77 | 0.836 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.6 | 4 | 0068-0425 | 935.39 | 425.27 | 246 | 64.28 | 0.748 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 251.1 | 4 | 0069-0426 | 227.43 | 425.84 | 276 | 63.60 | 0.857 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.7 | 4 | 0070-0433 | 826.67 | 433.62 | 366 | 73.01 | 0.863 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 215.1 | 4 | 0071-0433 | 792.34 | 434.04 | 296 | 65.26 | 0.874 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.2 | 4 | 0072-0439 | 880.69 | 439.79 | 390 | 75.84 | 0.852 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 232.3 | 4 | 0073-0458 | 342.98 | 457.95 | 303 | 68.53 | 0.811 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.9 | 4 | 0074-0466 | 560.47 | 466.09 | 336 | 71.01 | 0.837 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 260.8 | 4 | 0075-0477 | 753.31 | 477.02 | 509 | 85.50 | 0.875 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 236.3 | 4 | 0076-0487 | 519.08 | 487.44 | 347 | 70.43 | 0.879 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 269.8 | 4 | 0077-0489 | 901.11 | 489.35 | 224 | 59.70 | 0.790 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 238.2 | 4 | 0078-0497 | 148.51 | 496.66 | 310 | 65.60 | 0.905 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.9 | 4 | 0079-0504 | 288.85 | 504.09 | 327 | 67.26 | 0.908 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 272.6 | 4 | 0080-0502 | 21.26 | 502.29 | 265 | 65.60 | 0.774 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.2 | 4 | 0081-0502 | 230.11 | 502.30 | 295 | 68.43 | 0.792 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 218.2 | 4 | 0082-0507 | 702.74 | 507.36 | 250 | 59.94 | 0.874 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 231.1 | 4 | 0083-0518 | 434.28 | 517.40 | 308 | 65.60 | 0.899 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 252.9 | 4 | 0084-0517 | 327.21 | 518.02 | 295 | 65.60 | 0.861 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.2 | 4 | 0085-0532 | 654.71 | 531.73 | 370 | 71.36 | 0.913 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 222.0 | 4 | 0086-0535 | 143.11 | 534.87 | 285 | 64.18 | 0.869 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 232.4 | 4 | 0087-0536 | 197.18 | 535.93 | 334 | 68.18 | 0.903 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 263.4 | 4 | 0088-0538 | 519.41 | 538.85 | 295 | 65.01 | 0.877 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 225.6 | 4 | 0089-0547 | 598.89 | 547.62 | 236 | 57.11 | 0.909 |